SCHEMBL845355

SCHEMBL845355

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3CCc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccc1CCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
FKBP1A P62942 1/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
HSD17B10 Q99714 1/20 0.46
USP2 O75604 1/20 0.46
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
TSHR P16473 1/20 0.45
KDM1A O60341 1/20 0.45
RCOR1 Q9UKL0 1/20 0.45
ADRB2 P07550 1/20 0.45
PABPC1 P11940 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119320 0.91 ALDH1A1 (0.43) ALDH1A1FKBP1AMEN1KMT2AKDM4E
SCHEMBL845392 0.91 ALDH1A1 (0.51) ALDH1A1FKBP1AMEN1KMT2AKDM4E
SCHEMBL13272506 0.89 ALDH1A1 (0.41) ALDH1A1FKBP1AMEN1KMT2AKDM4E
SCHEMBL845131 0.88 PABPC1 (0.49) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845007 0.88 PABPC1 (0.49) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845682 0.83 ALDH1A1 (0.54) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL871691 0.83 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845005 0.83 KDM4E (0.54) ALDH1A1KDM4ELMNAHSD17B10CYP2C9
SCHEMBL845008 0.82 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ALMNACYP2C9
SCHEMBL13272394 0.82 MEN1 (0.47) ALDH1A1MEN1KMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed